Genome-Wide DNA Methylation in Early-Onset-Dementia Patients Brain Tissue and Lymphoblastoid Cell Lines.

Autores de IIS La Fe

• David Hervás Marín

  Autor

• Juan Sandoval Del Amor

  Autor

Participantes ajenos a IIS La Fe

• Ramos-Campoy, Oscar
• Comas-Alberti, Aina
• Borrego-Ecija, Sergi
• Bosch, Beatriz
• Fort-Aznar, Laura
• Moreno-Izco, Fermin
• Fernandez-Villullas, Guadalupe
• Molina-Porcel, Laura
• Balasa, Mircea
• Llado, Albert
• Sanchez-Valle, Raquel
• Antonell, Anna

Grupos

• Unidad de Biomarcadores y Medicina de Precisión (UBYMP)

Abstract

Epigenetics, a potential underlying pathogenic mechanism of neurodegenerative diseases, has been in the scope of several studies performed so far. However, there is a gap in regard to analyzing different forms of early-onset dementia and the use of Lymphoblastoid cell lines (LCLs). We performed a genome-wide DNA methylation analysis on sixty-four samples (from the prefrontal cortex and LCLs) including those taken from patients with early-onset forms of Alzheimer's disease (AD) and frontotemporal dementia (FTD) and healthy controls. A beta regression model and adjusted p-values were used to obtain differentially methylated positions (DMPs) via pairwise comparisons. A correlation analysis of DMP levels with Clariom D array gene expression data from the same cohort was also performed. The results showed hypermethylation as the most frequent finding in both tissues studied in the patient groups. Biological significance analysis revealed common pathways altered in AD and FTD patients, affecting neuron development, metabolism, signal transduction, and immune system pathways. These alterations were also found in LCL samples, suggesting the epigenetic changes might not be limited to the central nervous system. In the brain, CpG methylation presented an inverse correlation with gene expression, while in LCLs, we observed mainly a positive correlation. This study enhances our understanding of the biological pathways that are associated with neurodegeneration, describes differential methylation patterns, and suggests LCLs are a potential cell model for studying neurodegenerative diseases in earlier clinical phases than brain tissue.

Keywords

• Alzheimer's disease; frontotemporal dementia; lymphoblastoid cell lines; brain tissue; DNA methylation; diagnostic signature; epigenetic assessment